News Archive

Researchers from the DCRI are optimistic about the opportunities that wearable devices present in caring for patients with heart failure; however, they also recognize that challenges must be overcome to successfully interpret and act upon patient data collected from wearables.

A DCRI-led study is the first to test the performance of the Pooled Cohort Risk Equations, a commonly used tool for assessing cardiovascular risk, in older adults.

The DCRI’s Sarah Armstrong, MD, served as the lead author for a policy statement and a co-author on a technical report advocating for more widespread use of bariatric and metabolic surgeries for ch

A recent study from DCRI researchers found that patients who have had strokes may receive different care than those who have had heart attacks, despite evidence that shows statins are effective for secondary prevention in both populations to prevent recurring ischemic events.

Mixed results from the CABANA trial have led to debate about whether catheter ablation is an effective treatment option that provides benefit to patients with atrial fibrillation.

Women are less likely than men to receive statins, and those who do receive statins are more likely to receive a prescription below recommended guidelines. DCRI fellow Michael Nanna, MD (pictured), examined patient data from the PALM (Patient and Provider Assessment of Lipid Management) Registry in an effort to ascertain reasons for these differences. He and his team found that women are offered statins at lower rates but refuse or discontinue statins at higher rates than men.

Evidence supports that implantable cardioverter defibrillators still provide life-saving benefits, but more research is needed to improve the selection of patients for this treatment. Although it is incorrect to discount the potential benefit of implantable cardioverter defibrillators, it is also critical to improve selection criteria for patients who would derive the most benefit, writes the DCRI’s Sana Al-Khatib, MD, in two recent pieces on the topic.

A study led by a DCRI faculty member provides additional clarification on which patients may benefit the most from additional lipid-lowering therapies, if their cholesterol levels remain elevated despite optimal statin therapy.

Recent findings suggest that elevations in low-density lipoprotein cholesterol levels may not confer additional risk in populations 75 or older.

New findings from the DCRI suggest that how military service members interpret their pain may be able to predict pain-related costs and total medical costs.